sequence under fasting conditions and at least 7 days washout period between the doses.

Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Gabapentin Capsule (300 mg) relative to NEURONTINTM 300 mg in healthy Thai volunteers under fasting condition

A Bioequivalence study of a randomized, open-label, single dose, fully replicate crossover design with four-period, two-treatment and two-sequence of Atorvastatin 80 mg tablets relative to Lipitor(R) 80 mg tablets in healthy Thai volunteers under fasting condition